Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Global Trends and Innovations in Type 1 Diabetes: Incidence, Management, and Beta-Cell Preservation
Diabetes, Metabolic Syndrome and Obesity
- View all (3426)
- Volume 19, 2026 (164)
- Volume 18, 2025 (389)
- Volume 17, 2024 (428)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- Behavioral and Psychosocial Aspects in the Management and Treatment of Diabetes and Obesity (1)
- GLP-1 Agonists: The Game-Changers in Type 2 Diabetes and Obesity Care (5)
- From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health (1)
- The State of Diabetes, Metabolic Syndrome and Obesity (9)
- Managing obesity with pharmacotherapy (7)
- Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment (1)
- Emerging therapeutic targets of diabetic nephropathy (1)
Global Trends and Innovations in Type 1 Diabetes: Incidence, Management, and Beta-Cell Preservation
Concerns about the ongoing rise in Type 1 Diabetes (T1D) have been buoyed recently by exciting developments in approaches to easier, more effective management through automated insulin delivery and smart devices, as well as medication to delay T1D progression and use cell-based treatments—culminating in a true shift in the disease horizon. Given the importance of these shifts for the trajectory of the field of T1D and future management, Diabetes and Metabolic Syndrome here collects original research articles, reviews, and perspectives exploring global shifts in epidemiology, pathophysiology, and transformative technology and cell-based management.